Apple (NASDAQ:AAPL) had revenue of $117.15 billion in Q1 2023

Apple (NASDAQ:AAPL) revenue for the first quarter of fiscal 2023 was $117.15 billion, versus market expectations of $121.14 billion; Q1 IPHONE revenue was US$65.78 billion, market expectations were US$68.3 billion, first-quarter services revenue was US$20.77 billion, market expectations were US$20.47 billion, first-quarter Greater China revenue was US$23.91 billion, market expectations were US$21.8 billion;In the first quarter, Mac revenue was $7.74 billion, compared with market expectations of $9.72 billion; iPad revenue in the first quarter was $9.40 billion, market expectations were $7.78 billion; and first-quarter wearables, home and accessories revenue was $13.48 billion, market expectations were $15.32 billion.

Apple (NASDAQ:AAPL) had revenue of $117.15 billion in Q1 2023 Read Post »

Gilead Sciences’ (NASDAQ:GILD) Q4 2022 revenue of $7.4 billion was higher than market expectations

Gilead Sciences’ (NASDAQ:GILD) fourth-quarter 2022 revenue was $7.4 billion, versus analysts’ expectations of $6.64 billion. Veklury’s revenue in the fourth quarter was $1.00 billion, compared with analysts’ expectations of $533.2 million. Product sales are expected to be $26-26.5 billion in 2023, compared with analysts’ expectations of $25.38 billion. Veklury is expected to generate about $2 billion in revenue in 2023, compared with analysts’ expectations of $1.4 billion.

Gilead Sciences’ (NASDAQ:GILD) Q4 2022 revenue of $7.4 billion was higher than market expectations Read Post »

Starbucks (NASDAQ:SBUX) same-store sales up 5% in Q1 2023, analysts expect a 6.79% increase

Starbucks (NASDAQ:SBUX) same-store sales grew 5% in the first quarter of 2023, compared with analyst expectations of 6.79%; Net income for the first quarter of 2023 was $8.7 billion, compared to analysts’ expectations of $8.75 billion; North American same-store sales in the first quarter of 2023 increased by 10%, compared with analysts’ expectations of 9.54%; International same-store sales fell 13% in the first quarter of 2023, compared with analysts’ expectations of a 3.87% decline.

Starbucks (NASDAQ:SBUX) same-store sales up 5% in Q1 2023, analysts expect a 6.79% increase Read Post »

Amazon (NASDAQ:AMZN) net sales for Q4 2022 were $149.2 billion, versus analysts’ expectations of $145.8 billion

Amazon’s (NASDAQ:AMZN) net sales in the fourth quarter of 2022 were $149.2 billion, compared with analysts’ expectations of $145.8 billion; AWS net sales in the fourth quarter were $21.38 billion, compared with analysts’ expectations of $21.76 billion; net sales in the first quarter were expected to be $121-126 billion, compared with analysts’ expectations of $125.55 billion; fourth-quarter earnings per share were $0.030, compared with analysts’ expectations of $0.169; fourth-quarter operating profit was $2.7 billion, compared with analysts’ expectations of $2.51 billion.

Amazon (NASDAQ:AMZN) net sales for Q4 2022 were $149.2 billion, versus analysts’ expectations of $145.8 billion Read Post »

Google’s parent company Alphabet (NASDAQ:GOOGL) had revenue of $76.05 billion in Q4 2022

Google’s parent company Alphabet had revenue of $76.05 billion in the fourth quarter of 2022, compared with analysts’ expectations of $76.51 billion; Google services revenue in the fourth quarter was $67.84 billion, compared with analysts’ expectations of $68.9 billion; Google Cloud revenue in the fourth quarter was $7.32 billion, analysts expected $7.3 billion; fourth-quarter earnings per share were $1.05, analysts expected $1.179; and fourth-quarter net profit was $13.624 billion, analysts expected $15.361 billion.

Google’s parent company Alphabet (NASDAQ:GOOGL) had revenue of $76.05 billion in Q4 2022 Read Post »

Qualcomm Inc.(NASDAQ:QCOM) adjusted revenue for Q1 2023 was $9.46 billion

Qualcomm’s (NASDAQ:QCOM) adjusted revenue for the first quarter of 2023 was $9.46 billion, compared to analysts’ expectations of $9.61 billion; first-quarter adjusted earnings per share were $2.37 versus analysts’ expectations of $2.35; second-quarter revenue was expected to be $8.7 billion to $9.5 billion, compared with analysts’ expectations of $9.58 billion; and second-quarter adjusted earnings per share were expected to be $2.05 to $2.25, versus analysts’ expectations of $2.29.

Qualcomm Inc.(NASDAQ:QCOM) adjusted revenue for Q1 2023 was $9.46 billion Read Post »

Piper Sandler: Upgraded Meta Platforms (NASDAQ:META) from neutral to overweight

Piper Sandler analyst Thomas Champion upgraded Meta Platforms (NASDAQ:META) to overweight from neutral and raised its price target to $215 from $136. The analyst said in the research note that Meta’s spending guidance for fiscal 2023 was significantly lowered, resulting in a “significant increase” in free cash flow forecasts. Analysts believe that despite the difficulties in the advertising market and the fact that the company’s investment in the metaverse space has not compromised, the dramatic change in this quarter’s results justifies the company to receive a more constructive rating.

Piper Sandler: Upgraded Meta Platforms (NASDAQ:META) from neutral to overweight Read Post »

Estée Lauder (NYSE:EL) net sales for Q2 2023 were $4.620 billion, down 17% year-over-year

Estée Lauder (NYSE:EL) reported Q2 2023  financial results, with Q2 net sales of $4.620 billion, down 17% year-over-year; Net income attributable to the company was $394 million, down 64% year-over-year. The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD BEAUTY, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.

Estée Lauder (NYSE:EL) net sales for Q2 2023 were $4.620 billion, down 17% year-over-year Read Post »

Meta Platforms (NASDAQ:META) expects investments to drive corporate spending to continue to rise in 2023

Meta Platforms (NASDAQ:META) said expected investments in data center capacity, servers, network infrastructure and number of employees will drive the company’s expenses to continue to rise in 2023, which is expected to adversely affect operating margins and profitability.

Meta Platforms (NASDAQ:META) expects investments to drive corporate spending to continue to rise in 2023 Read Post »

JPMorgan Chase: Raised Meta Platforms (NASDAQ:META) price target to $225 from $150

JPMorgan Chase & Co. pointed out that Meta Platforms (NASDAQ:META) exceeded expectations in Q4 last year, and CEO Zuckerberg designated 2023 as the “year of efficiency”, in sharp contrast to last year’s Q3 earnings report, and believes that its current internal policy will promote long-term development. The bank pointed out that the results showed that Meta performed well in a challenging macro environment, with improved e-commerce ad spending, strong growth in Instagram short video platforms Reels and click-through advertising (CTM), innovation driven by artificial intelligence technology, and changes in platform privacy protection measures. Lower costs have been the biggest driver in the near term, with Meta expecting total spending to fall by $5 billion this year to $89 billion to $95 billion, beating expectations. Xiaomo said that it remained bullish on Meta, raising its target price to $225, corresponding to the 2024 GAAP EPS forecast of about 17.5 times, reiterating

JPMorgan Chase: Raised Meta Platforms (NASDAQ:META) price target to $225 from $150 Read Post »

Bank of America Securities: Lowered Pfizer (NYSE:PFE) price target to $50 with neutral rating

Bank of America Securities released a research report saying that Pfizer’s (NYSE:PFE) guidance for this year’s results indicates that the company expects pandemic-related revenue to decline by more than 60%, resulting in total revenue falling about 30% from the middle of the guidance. The bank said that while it was not surprised by the slowdown in demand, the magnitude of the decline and profit margins affected EPS guidance. Non-COVID-related revenues were also weaker, partially offset by poor performance on the Ibrance and Eliquis franchises. The bank believes investors have been focusing on non-COVID-related businesses given the uncertainty surrounding growth prospects in the post-pandemic period. The report mentioned that Pfizer highlighted several upcoming products that may improve investor sentiment. However, the bank believes they are unlikely to ease growth concerns. The bank continues to be cautious about the group’s long-term growth prospects, with revenue expected to grow at a CAGR of

Bank of America Securities: Lowered Pfizer (NYSE:PFE) price target to $50 with neutral rating Read Post »

Scroll to Top